These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10837540)
1. Antibody-directed enzyme prodrug therapy (ADEPT): a review. Springer CJ; Niculescu-Duvaz I Adv Drug Deliv Rev; 1997 Jul; 26(2-3):151-172. PubMed ID: 10837540 [TBL] [Abstract][Full Text] [Related]
2. Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs. Springer CJ; Niculescu-Duvaz I Anticancer Drug Des; 1995 Jul; 10(5):361-72. PubMed ID: 7639927 [TBL] [Abstract][Full Text] [Related]
3. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT). Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273 [TBL] [Abstract][Full Text] [Related]
4. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate. Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478 [TBL] [Abstract][Full Text] [Related]
6. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT). Biela BH; Khawli LA; Hu P; Epstein AL Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121 [TBL] [Abstract][Full Text] [Related]
7. Antibody directed enzyme prodrug therapy (ADEPT) and related approaches for anticancer therapy. Jung M Mini Rev Med Chem; 2001 Nov; 1(4):399-407. PubMed ID: 12369965 [TBL] [Abstract][Full Text] [Related]
8. Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Syrigos KN; Epenetos AA Anticancer Res; 1999; 19(1A):605-13. PubMed ID: 10226606 [TBL] [Abstract][Full Text] [Related]
9. Antibody-enzyme conjugates for cancer therapy. Melton RG; Sherwood RF J Natl Cancer Inst; 1996 Feb; 88(3-4):153-65. PubMed ID: 8632489 [TBL] [Abstract][Full Text] [Related]
10. Strategies for enzyme/prodrug cancer therapy. Xu G; McLeod HL Clin Cancer Res; 2001 Nov; 7(11):3314-24. PubMed ID: 11705842 [TBL] [Abstract][Full Text] [Related]
11. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843. Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962 [TBL] [Abstract][Full Text] [Related]
12. Targeted enzyme prodrug therapies. Schellmann N; Deckert PM; Bachran D; Fuchs H; Bachran C Mini Rev Med Chem; 2010 Sep; 10(10):887-904. PubMed ID: 20560876 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential of Prodrugs Towards Targeted Drug Delivery. Mishra AP; Chandra S; Tiwari R; Srivastava A; Tiwari G Open Med Chem J; 2018; 12():111-123. PubMed ID: 30505359 [TBL] [Abstract][Full Text] [Related]
14. Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study. Springer CJ; Poon GK; Sharma SK; Bagshawe KD Cell Biophys; 1994; 24-25():193-207. PubMed ID: 7736524 [TBL] [Abstract][Full Text] [Related]
15. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Tietze LF; Schmuck K Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425 [TBL] [Abstract][Full Text] [Related]
16. Systems biology and the mathematical modelling of antibody-directed enzyme prodrug therapy (ADEPT). Varner JD Syst Biol (Stevenage); 2005 Dec; 152(4):291-302. PubMed ID: 16986273 [TBL] [Abstract][Full Text] [Related]